For research use only. Not for therapeutic Use.
Iralukast sodium is a leukotriene receptor antagonist that was investigated for its potential use in treating respiratory conditions such as asthma. By blocking leukotriene receptors, Iralukast sodium can reduce bronchoconstriction, inflammation, and mucus production, which are key factors in asthma and allergic reactions. Although it showed promise in early studies for managing asthma symptoms and improving respiratory function, it did not achieve widespread clinical use. Its development contributed to the understanding and advancement of leukotriene-modulating therapies in respiratory care.
| Catalog Number | I011858 |
| CAS Number | 125617-94-9 |
| Synonyms | iralukast; CGP 45715A |
| Molecular Formula | C38 H37 F3 O8 S . Na |
| Purity | ≥95% |
| Target | Leukotriene Receptor |
| Storage | -20°C |
| InChIKey | UVMDAJYLEKEIPJ-RWRWEHELSA-M |
| SMILES | [Na+].c1(cc(c2c(o1)cc(cc2)S[C@@H](C=CC=C/CCCCOc1c(c(c(cc1)C(=O)C)O)CCC)[C@@H](c1cc(ccc1)C(F)(F)F)O)=O)C(=O)[O-] |
